Cover Image

Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: A pharmacovigilance experience utilizing an ADR trigger tool

Background: Since the World Health Organization declared coronavirus disease (COVID-19) as a pandemic, most countries started treating their patients with various therapies. However, the data regarding their safety and effectiveness is still lacking. Objectives: We aimed to evaluate the adverse drug...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bashayer Alshehail (Author), Zainab Al Jamea (Author), Royes Chacko (Author), Fawaz Alotaibi (Author), Nadia Ismail (Author), Dhafer Alshayban (Author)
Format:	Book
Published:	Elsevier, 2022-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Children and ADRs (Adverse Drug Reactions)
by: Napoleone Ettore
Published: (2010)

Incidence and Risk Factors of Colistin-Induced Nephrotoxicity Associated with The International Consensus Guidelines for the Optimal Use of the Polymyxins: A Retrospective Study in a Tertiary Care Hospital, Saudi Arabia
by: Fawaz M. Alotaibi, et al.
Published: (2022)

Adverse Drug Reactions (ADRs) of Montelukast in Children
by: Abdullah Al-Shamrani, et al.
Published: (2022)

Patterns of adverse drug reactions (ADRs) in Saudi Arabia
by: Nora Bin Yousef, et al.
Published: (2022)

Adverse drug reactions (ADRs) in geriatric hospitalized patients
by: Fita Rahmawati, et al.
Published: (2008)

Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia
by: Md. Ashraful Islam, et al.
Published: (2020)

Adverse Drug Reactions, Power, Harm Reduction, Regulation and the ADRe Profiles
by: Sue Jordan, et al.
Published: (2018)

Analysis of cutaneous adverse drug reactions reported at the regional ADR monitoring center
by: Anal Modi, et al.
Published: (2019)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)
by: Stefania Chiappini, et al.
Published: (2022)

Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
by: Kriteeka Saini, et al.
Published: (2022)

Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana
by: Abena Ahwianfoa Yawson, et al.
Published: (2022)

A Data-Driven Reference Standard for Adverse Drug Reaction (RS-ADR) Signal Assessment: Development and Validation
by: Suehyun Lee, et al.
Published: (2022)

Adverse Drug Reactions:A Retrospective Analysis from the ADR Monitoring Centre at a Tertiary Care Hospital
by: Fehmi Mushta Mukadam, et al.
Published: (2024)

Pharmacovigilance in oncology: pattern of spontaneous notifications, incidence of adverse drug reactions and under-reporting
by: Marília Berlofa Visacri, et al.
Published: (2014)

Explore Adverse Drug Reactions (ADRs) reporting by clinical and community pharmacists in Duhok, Kurdistan region- Iraq: hampered and perspective
by: Omer Allela
Published: (2022)

Investigating the Reasons for Failing to Report Adverse Drug Reactions (ADR) by Nurses of Neonatal Intensive Care Unit in the Year 2015
by: Mahtab Mahboubi, et al.
Published: (2017)

An observational study on adverse reactions of cosmetics: The need of practice the Cosmetovigilance system
by: Jisha M. Lucca, et al.
Published: (2020)

Incidence of Adverse Drug Reactions (ADRs) and their Determinants among Sputum-Positive Pulmonary TB Patients in A Metropolitan Area, Bengaluru: A Prospective Study
by: Manasa Divakar, et al.
Published: (2023)

Pharmacovigilance study of tyrosine kinase inhibitors: Analysis of adverse reactions
by: Antoan Rangelov, et al.
Published: (2024)

Effect of zinc supplementation on symptom reduction and length of hospital stay among pediatric patients with Coronavirus disease 2019 (COVID-19)
by: Ghufran Ibrahim Alhajjaji, et al.
Published: (2023)

Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine
by: Ostermann Thomas, et al.
Published: (2009)

Pharmacovigilance and incidence of adverse drug reactions in hospitalized pediatric patients: a mini systematic review
by: Zakir Khan, et al.
Published: (2020)

Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety
Published: (2020)

Pharmacovigilance: profile and notifications of the adverse drug reaction in a teaching hospital
by: Kattlyn Laryssa CANDIDO, et al.
Published: (2023)

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal
by: Sunil Shrestha, et al.
Published: (2020)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
by: Hadi MA, et al.
Published: (2017)

CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED Study
by: Katja S. Just, et al.
Published: (2021)

Knowledge, Attitude, and Practice Regarding Pharmacovigilance and Barriers to Reporting Adverse Drug Reactions Among the General Population in Saudi Arabia
by: Alshehri H, et al.
Published: (2024)

Correction to: Amid COVID-19: the importance of developing an positive adverse drug reaction (ADR) and medical device incident (MDI) reporting culture for Global Health and public safety
Published: (2020)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
by: Zakir Khan, et al.
Published: (2020)

Pharmacy students' knowledge and perceptions about adverse drug reactions reporting and pharmacovigilance
by: Kingston Rajiah, et al.
Published: (2016)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
by: Kishor A Bansod, et al.
Published: (2020)

Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
by: Ernestina Hernández García, et al.
Published: (2023)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
by: Cristina Scavone, et al.
Published: (2020)

Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China
by: Xiaofang Tan, et al.
Published: (2020)

Pharmacovigilance Program impact on notifications of adverse reactions to antineoplastic drug in a university hospital
by: Carlos Alberto WAYHS, et al.
Published: (2024)

A survey of drive-thru pharmacy services: Evaluating the acceptance and perspectives of community pharmacists in Saudi Arabia
by: Ibrahim M. Asiri, et al.
Published: (2024)

Adverse Drug Reaction (ADR) of Hydroxychloroquine(HCQ) in the -Preexposure Prophylaxis (PrEP) of COVID-19 in Health Care Professionals in a Tertiary Care Teaching Hospital
by: Pranav S Jadhav, et al.
Published: (2023)

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions
by: Pierre Karapetiantz, et al.
Published: (2018)

Use of a trigger tool to detect adverse drug reactions in an emergency department
by: Silvana Maria de Almeida, et al.
Published: (2017)